William Creasman to Neoplasm Invasiveness
This is a "connection" page, showing publications William Creasman has written about Neoplasm Invasiveness.
Connection Strength
0.708
-
Why do we continue to overtreat stage Ia?carcinoma of the cervix? Am J Obstet Gynecol. 2017 10; 217(4):413-417.
Score: 0.130
-
Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases? Gynecol Oncol. 2016 08; 142(2):278-82.
Score: 0.122
-
How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery? Am J Obstet Gynecol. 2009 Sep; 201(3):260.e1-3.
Score: 0.075
-
Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S105-43.
Score: 0.063
-
Vaginal cancers. Curr Opin Obstet Gynecol. 2005 Feb; 17(1):71-6.
Score: 0.056
-
Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study. Am J Obstet Gynecol. 1998 Jan; 178(1 Pt 1):62-5.
Score: 0.034
-
The National Cancer Data Base report on early stage invasive vulvar carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1997 Aug 01; 80(3):505-13.
Score: 0.033
-
Limited disease: role of surgery. Semin Oncol. 1994 Feb; 21(1):79-83.
Score: 0.026
-
Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer. Am J Obstet Gynecol. 2008 Aug; 199(2):196.e1-7.
Score: 0.018
-
Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987 Oct 15; 60(8 Suppl):2035-41.
Score: 0.017
-
Papanicolaou smear history of patients developing cervical cancer: an assessment of screening protocols. Obstet Gynecol. 1987 Feb; 69(2):151-5.
Score: 0.016
-
Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S145-60.
Score: 0.016
-
Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S161-92.
Score: 0.016
-
Gestational trophoblastic neoplasia. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S193-203.
Score: 0.016
-
Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S29-42.
Score: 0.016
-
Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S43-103.
Score: 0.016
-
Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S7-27.
Score: 0.016
-
Stage II carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 1979 Mar; 5(3):323-6.
Score: 0.009
-
Conservative surgical management of superficially invasive stage I vulvar carcinoma. Gynecol Oncol. 1989 Dec; 35(3):352-7.
Score: 0.005
-
Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report). Cancer. 1985 Jul 15; 56(2):243-8.
Score: 0.004
-
Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol. 1985 Apr 15; 151(8):1009-15.
Score: 0.004
-
Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol. 1984 Jun; 63(6):825-32.
Score: 0.003